Characterization of murine cytomegalovirus 34 kDa glycoprotein that forms a complex with the cell-surface MHC class I molecules

Periodicum Biologorum

Volumn 100, Issue 4, 1998, Pages 469-476

  Kučić, Natalia ^a   Jonjić, Stipan ^a   Koszinowski, Ulrich H ^b   Lučin, Pero ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CYTOMEGALOVIRUS; ENDOPLASMIC RETICULUM; FIBROBLAST; GLYCOPROTEIN SYNTHESIS; IMMUNOPRECIPITATION; ISOELECTRIC FOCUSING; MOUSE; NATURAL KILLER CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RADIOIODINATION; TIME; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALIA; CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0032420410     PISSN: 00315362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. AHN K, ANGULO A, GHAZAL P, PETERSON P, YANG Y, FRUEH K 1996 Human cytomegalovirus inhibit antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 93: 10990-10995
2. BÜHLER B, KEIL G M, WEILAND F, KOSZINOWSKI U H 1990 Characterization of the murine cytomegalovirus early transcription unite el that is induced by immediate-early proteins. J Virol 64: 1907-1919
3. DEL VAL M, HENGEL H, HÄCKER H, HARTLAUB U, RUPPERT T, LUČIN P, KOSZINOWSKI U H 1992 Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med 176: 729-738
4. FARELL H E, VALLY H, LYNCH D M, FLEMING P, SHELLAM G R, SCALZO A A DAVISPOYNTER N J 1997 Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386: 510-514
5. HEEMELS M-T, PLOEGH H 1995 Generation, translocation and presentation of MHC class I - restricted peptides. Annu Rev Biochem 64: 463-9
6. HENGEL H, KOOPMANN J-O, FLOHR T, MURANYI W, GOULMY E, HAMMERLING G J, KOSZINOWSH U H, MOMBURG F 1997 A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6: 623-632
7. + T cell derived IFNγ combats viral escape. J Virol 68: 289-297
8. JONES P P 1984 Analysis of H-2 and Ia antigens by two-dimensional polyacrylamide gel electrophoresis. Methods Enzymol 108: 452-465
9. JONES T R, HANSON L K, SUN L, SLATER J S, STENBERG R M, CAMPBELLA 1995 Multiple independent to within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex dass I heavy chains. J Virol 69: 4830-4841
10. + T lymphocytes. J Virol 64: 5457-5464
11. JONJIĆ S, PAVIĆ I, POLIĆ B, CRNKOVIĆ I, LUČIN P, KOSZINOWSKI U H, 1994 Antibodies are not essential for resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Expl Med 179: 1713-1717
12. KLEIJNEN M M F, HUPPA J B, LUČIN P, MUKHERJEE S, FARRELL H, CAMBPELL A, KOSZINOWSKI U H, HILL A B, PLOEGH H L 1997 A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but transported to the cell surface. EMBO J 16: 684-694
13. KOSZINOWSKI U H, JONJIĆ S, LUČIN P 1994 Cytomegalovirus persistence by evasion from immune control. Semin Virol 5: 297-305
14. LIAO N S, BIX M, ZIJLSTRA M, JENISCH R, RAULET D 1991 MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253: 199-202
15. LUČIN P, JONJIĆ S 1995 Cytomegalovirus replication cycle: An overwiev. Period Biol 97: 3-22
16. LUČIN P, JONJIĆ S, MESSERLE M, POLIĆ B, HENGEL H, KOSZINOWSKI U H 1994 Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumor necrosis factor. J Gen Virol 75: 101-110
17. LUČIN P, PAVIĆ I, POLIĆ B, JONJIĆ S, KOSZINOWSKI U H 1992 IFN-gamma dependent clearance of cytomegalovirus infection in salivary glands. J Virol 66: 1977-1984
18. LJUNGGREN H G, KARRE K 1990 In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 11: 237-243
19. PLOEGH H L 1998 Viral strategies of immune evasion. Science 280: 248-253.
20. POLIĆ B, HENGEL H, KRMPOTIĆ A, TRGOVCICH J, PAVIĆ I, LUČIN P, JONJIĆ S, KOSZINOWSKI U H 1998 Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188: 1047-1054.
21. RAWLINSON W D, FARRELL H E, BARRELL B G 1996 Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70: 8833-8849
22. REUSCH U, MURANYI W, LUČIN P, BURGERT H-G, HENGEL H, KOSZINOWSKI U H 1998 A cytomegalovirus glycoprotein reroutes MHC class I complexes to lysosomes for degradation. (submitted)
23. REYBURN H T, MANDELBOIM O, VALES-GOMEZ M, DAVIS D M, PAZMANY L, STROMINGER J L 1997 The class IMHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386: 514-517
24. THÄLE R, LUČIN P, SCHNEIDER K, EGGERS M, KOSZINOWSKI U H 1994 Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol 68: 7757-7765
25. THALE R, SZEPAN U, HENGEL H, GEGINAT G, LUČIN P, KOSZINOWSKI U H 1995 Identification of the mouse cytomegalovirus genomic region affecting MHC class I molecule transport. J Virol 69: 6098-6105
26. WIERTZ E J H J, JONES T R, SUN L, BOGYO M, GEUZE H J, PLOEGH H L 1996 The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779
27. WIERTZ E J H J, TORTORELLA D, BOGYO M, YU J, MOTHES W, JONES T R, RAPOPORT T A, PLOEGH H 1996 Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384: 432-438
28. ZIEGLER H, THÄLE R, LUČIN P, MURANYI W, FLOHR T, HENGEL H, FARRELL H, RAWLINSON W, KOSZINOWSKI U H 1997 A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6: 57-66